AIDS Treatment News Index, 2001

AIDS Treatment News Index, 2001

20th year of AIDS 364
911 371
Abacavir 373
Access, international (see Global epidemic)
ACT UP Philadelphia 367
ADAP program 366
ADAP program 371
Africa (see also South Africa)
Africa -- home care 361
Africa 359
Africa 360
Africa 363
Africa 371
Africa 372
Africa 373
African American conference 376
African Americans 359
Agenerase 373
AIDS research -- 20 views 368
AIDS Treatment Activist Coalition 370
AIDSWatch 362
AmFAR HIV/AIDS Treatment Directory 363
AmFAR Treatment Insider 362
Amprenavir 373
Antibodies and HIV 365
Antibody testing 374
Antibody testing 375
Antiretrovirals list 372
ATAC 370
Barcelona (see International AIDS Conference)
Bioterrorism--immune research 373
Bone disease 366
Brazil 359
Bristol-Myers Squibb 361
Buenos Aires conference 368
Buenos Aires conference 369
Burkina Faso 363
Busch, Barry 367
Buyers' club list 376
Cameron, Justice Edwin 368
CD4 count 364
Civil society 365
Cohen, Jon 367
Coinfection (HIV and HCV) 371
Conference reports on Web 373
Counterfeit drugs 365
d4T+ddI 358
Denialists 364
Denialists 374
Denialists 375
Denialists, AIDS Treatment News series 376
Developing countries (see Access, international)
Direct action 364
Doctors Without Borders (see MSF)
Doha 371
Drug donations 361
Efavirenz 362
Efavirenz 373
European parliament 363
Fact sheets 358
FDA 362
FDA 369
Fibrosis 370
Funding -- international (see Global epidemic)
Garlic 375
GB virus C 372
Gilead Sciences (see Tenofovir)
GlaxoSmithKline 360
GlaxoSmithKline 371
GlaxoSmithKline 372
Global epidemic 362
Global epidemic 363
Global epidemic 367
Global epidemic 369
Global epidemic 370
Global epidemic 372
Global epidemic 373
Guidelines 361
Heart disease 370
Hepatitis C 359
Hepatitis C 371
Hepatitis 375
HIV drugs 372
HIV incidence 359
HIV prevention 364
HIV resistance 368
HIV testing, part I of II 374
HIV testing, part II of II 375
Homocysteine 370
IAPAC 369
IAS Conference 368
IAS Conference 369
ICAAC conference 375
ICAAC conference 376
Immune-based treatment 360
Innate immune system 373
Intellectual property -- patent proposal 366
Intellectual property (see also Global epidemic)
Intellectual property 359
Intellectual property 360
Intellectual property 363
Intellectual property 371
Interaction, garlic & saquinavir 375
Intermittent treatment 375
International (see Global epidemic)
International AIDS Candlelight Memorial 364
International AIDS Conference 372
International AIDS Conference 376
Johns Hopkins Report 361
Kaletra 362
Kaletra 373
Liver (see Hepatitis)
Liver fibrosis 370
Malawi 371
Marijuana Policy Project 376
Maternal infant transmission 364
Maternal transmission lawsuit 374
Medical marijuana 376
Medscape 369
Merck 361
Merck 367
Mirken, Bruce 376
Mitochondrial toxicity 366
MSF 361
Names reporting 367
NATAF 370
Nevirapine 358
Nevirapine 374
New Mexico AIDS InfoNet 358
North American AIDS Treatment Action Forum 370
Pediatric AIDS 374
Pharmacokinetics 375
Pipeline (HIV drugs) 372
Post-exposure prophylaxis 358
Pregnancy 358
Protease inhibitors 370
Protease inhibitors 375
Research -- 20 views 368
Resistance conference 368
Resistance prevalence 376
Resistance tests 374
Retroviruses conference 2001 359
Retroviruses conference 2001 361
Retroviruses conference 2002 372
Richman, Douglas 376
Salvage therapy 362
San Francisco 359
Saquinavir 373
Saquinavir 375
Scondras, David 371
Social organization 367
South Africa 359
South Africa 360
South Africa 361
South Africa 364
South Africa 368
South Africa 374
STI (structured treatment interruption) 369
Structured intermittent therapy 375
Sustiva 362
Sustiva 373
Syringe prescription 364
T-20 373
TAC (Treatment Action Campaign) 374
TAG (Treatment Action Group) 364
TAG (Treatment Action Group) 369
T-cell (CD4) count 364
Tenofovir 360
Tenofovir 364
Tenofovir 370
Tenofovir 372
Tenofovir approved 373
Therapeutic drug monitoring 363
Trade rules 371
Treatment access 359
Treatment guidelines (see Guidelines) 361
Treatment interruption 369
Treatment vs. prevention controversy 362
Treatment vs. prevention controversy 365
Tuberculosis guidelines 371
Twinning organizations 363
UNGASS 359
UNGASS 365
UNGASS 366
UNGASS 367
United Nations (see UNGASS)
Vaccines 359
Vaccines 367
Viral load 6-day changes 374
Viral load 364
Viramune 374
ViroLogic 376
Women, treatment 368
Women, treatment 372
World AIDS Day 373
Ziagen 373